Please login to the form below

ICS

This page shows the latest ICS news and features for those working in and with pharma, biotech and healthcare.

AZ prepares to file COPD triple, taking on rival GSK

The KRONOS trial of PT010 – which combines long-acting beta agonist (LABA) formoterol fumarate, long-acting muscarinic antagonist (LAMA) glycopyrronium and inhaled corticosteroid (ICS) budesonide – was presented at a medical congress ... triple –

Latest news

AZ rival to GSK’s COPD drug Anoro fails head-to-head test

The real battleground between the two companies is expected to be three-drug combinations for COPD, with an inhaled corticosteroid (ICS) added to the LAMA/LABA duo.
AZ’s COPD triple data sets up market clash with GSK

on LABA vilanterol, LAMA umeclidinium and ICS fluticasone furoate - in the US and Europe last year.
EMA approves GSK’s triple COPD therapy

moderate to severe COPD who are not adequately treated by the combination of an inhaled corticosteroid (ICS) and a long-acting beta agonist (LABA). ... The same indication was approved by the FDA in September, and makes Trelegy the first drug on the
With US approval, GSK now needs rapid uptake for COPD triple

The three-drug product delivers a long-acting beta agonist (LABA), a long-acting muscarinic antagonist (LAMA) and an inhaled corticosteroid (ICS) from a single device, and is the first product
GSK closes in on EU approval for triple COPD therapy

The new product adds long-acting muscarinic receptor antagonist (LAMA) umeclidinium to the ICS/LABA combination, which has proved so successful in GSK's big-selling Advair/Seretide (fluticasone propionate/salmeterol) ... The benefits of Trelegy/Elebrato -

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest Intelligence

Deal Watch table for August 2014

600. TARIS Biomedical/ Allergan. Company acquisition. LiRIS for interstitial cystitis / bladder pain syndrome (IC/BPS) (phase II).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

How can pharma engage with key stakeholders on NHS service transformation?

It should also be noted that in the 14 areas, which are early movers from STP to ICS/ICPPs (Integrated Care Provider Partnerships), former low-mid ranking CCG commissioners and project
Raising Awareness: It’s World COPD Day today!

Inhaled corticosteroids (ICS) are another COPD treatment used to reduce inflammation in the lungs. ... Interestingly, no advantage in adding ICS to bronchodilator therapy in patients at low risk of exacerbations has been observed.
Managing local population needs is key for the NHS

year. These plans should “ align key assumptions on income, expenditure, activity and workforce” and system leaders within the ICS are expected to take an “ active role in this process”. ... efficiencies. Conclusion. STPs and the newly emerging
How can pharma engage with key decision-makers in new, collaborative NHS care models?

This has resulted in an increasingly complex, multi-layered healthcare system that is seeing some GPs taking on wide-ranging responsibilities in Integrated Care System (ICS) areas. ... work in an alliance within the ICS.
Large-scale NHS commissioning models require new partnership approach from pharma

Some of the mergers have been entered into voluntarily to help cut costs and ultimately pave the way for the introduction of Accountable or Integrated Care System (ACS/ICS) models; while

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Healthcare PR Director: £100, 000 – £120, 000 benefits

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Account Manager: Negotiable

Senior Account Manager / Account Director - Medical Education – ...: Salary TBC

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Sudler London - Account Director: Competitive

Account Director, Healthcare Advertising Agency: Salary TBC

Account Director or Senior Account Director: Salary TBC

Graduate Scientific Editor: DOE

Account Manager- 4 days per week or full-time: Salary TBC

Associate Scientific Director: Salary TBC

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Senior Medical Writer, MedComms Agency: Salary TBC

Senior Training Manager - Surrey: Competitive Salary &Bonus

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Account Manager, Healthcare Advertising: £30 - 38, 000 (or -)

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Healthcare PR Senior Account Manager: Salary TBC

Medical Writers Required - Hertfordshire: Competitive

Senior Writer, Healthcare Advertising, London: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....